| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Immunoglobulin Light Chains in Myelomas with Nonamyloid (Randall-Type) Light Chain Deposition Disease
From the Laboratoire d'Immunologie,*
Centre National de
la Recherche Scientifique (CNRS) EP118, Faculté de
Médecine, and Institut Universitaire de
France,**
Limoges, France; Département de
Néphrologie,
Centre Hospitalier
Universitaire La Milètrie, Poitiers, France; Laboratoire
d'Immunologie,
CNRS ESA 6031, CHU La
Milètrie, Poitiers, France; Service d'Anatomie
Pathologique,¶
INSERM U423 Hôpital
Pitié-Salpètrière, Paris; Service
d'Immunochimie,||
Hôpital
Pitié-Salpêtrière, Paris, France; and Department of
Pathology,§
New York University Medical Center,
New York, New York
We herein report on the first two primary sequences
(BOU and RAC) of monoclonal light chains
of the
type responsible for nonamyloid
light chain deposition
disease. Both patients were affected with severe forms of myeloma
complicated with renal failure. The pathological presentation typically
featured Congo red-negative deposits along tubular basement membranes
but differed somewhat from the typical "Randall-type"
light
chain deposition disease: they lacked the prominent glomerulosclerosis
pattern often featuring nonamyloid
deposits and were associated
with cylinders or myeloma casts. Both protein sequences were deduced
from those of the corresponding complementary DNAs in the bone marrow
plasma cells. For each chain, products of three independent
amplifications by polymerase chain reaction were sequenced and found to
be identical. BOU and RAC
mRNAs had a
normal overall structure consisting of V
2 segments rearranged to
J
2C
2 but displayed a number of unusual features within their
primary sequences. These substitutions are likely responsible for
changes in light chain conformation that promote their aggregation and
deposition along renal tubule basement membranes.
This article has been cited by other articles:
![]() |
S. M. Korbet and M. M. Schwartz Multiple Myeloma J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2533 - 2545. [Full Text] [PDF] |
||||
![]() |
C. Sirac, F. Bridoux, C. Carrion, O. Devuyst, B. Fernandez, J.-M. Goujon, C. E. Hamel, J.-C. Aldigier, G. Touchard, and M. Cogne Role of the monoclonal {kappa} chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome Blood, July 15, 2006; 108(2): 536 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decourt, H. R. Galea, C. Sirac, and M. Cogne Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias J. Leukoc. Biol., September 1, 2004; 76(3): 528 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vidal, F. Goni, F. Stevens, P. Aucouturier, A. Kumar, B. Frangione, J. Ghiso, and G. Gallo Somatic Mutations of the L12a Gene in V-{kappa}1 Light Chain Deposition Disease : Potential Effects on Aberrant Protein Conformation andDeposition Am. J. Pathol., December 1, 1999; 155(6): 2009 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decourt, A. Rocca, F. Bridoux, F. Vrtovsnik, J.L. Preud'homme, M. Cogne, and G. Touchard Mutational Analysis in Murine Models for Myeloma-Associated Fanconi's Syndrome or Cast Myeloma Nephropathy Blood, November 15, 1999; 94(10): 3559 - 3566. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |